The San Raffaele Scientific Institute: past, present and future

Since the beginning of the ’90s Molecular Medicine has been the characterizing element of our institutional research, which is focused on the comprehension of molecular processes of disease and on the clinical applications of molecular biology results. In other words, specific attention is given to translational research aimed at transferring the results obtained in the lab to the patients’ bed.

The mission of the Research Institute can be summarized as follows:

  • Perform cutting edge science;
  • Advance knowledge on human diseases;
  • Identify new therapies to the benefit of patients;
  • Provide the best environment to foster the development of young scientists and doctors.

Translational medicine, the bench-to-bed-to-bench transfer of information and results, is our vision and the future for the Institute. We intend to consolidate our standing as a leading national and international Health Care Center where translational medicine provides each and every patient the best, most appropriate and most advanced treatment available.

All research activities are organized in 6 Research Divisions and 2 Research Centers. Moreover, 3 Research Institutes conduct research activities on specific themes of research: TIGET, (San Raffaele Telethon Institute for Gene Therapy), INSPE, (Institute of Experimental Neurology), and DRI, (Diabetes Research Institute).

San Raffaele scientists in 2012 produced a total of 1107 publications, 8% of which appeared in the top level scientific journals (IF greater than 10), and this resulted in our Institute ranking first among Italian IRCCS in terms of scientific productivity.

San Raffaele is also home to clinical trials and its research generates patents through which scientific results can be turned into new therapies or new diagnostic approaches with industrial support.

We are confident that through the efforts and enthusiasm of scientists, doctors, students and everyone who works at the San Raffaele, our research will continue to be successful in leading to the discovery of new diagnostic and therapeutic strategies to the benefit of patients.